TickerKhojComparison · NSE · data 2026-11-02
Nephrocare Health Services Limited vs Vijaya Diagnostic Centre Ltd.
In plain words
Size: Vijaya Diagnostic Centre Ltd. is about 2.4 times the market value of Nephrocare Health Services Limited.
Return on equity: Vijaya Diagnostic Centre Ltd. 19.7% vs Nephrocare Health Services Limited 9%.
Debt to equity: Vijaya Diagnostic Centre Ltd. 0.44 vs Nephrocare Health Services Limited 0.07.
Differences in the numbers, not a recommendation of either stock.
Side by side
| NEPHROPLUS | VIJAYA | |
|---|---|---|
| Price | ₹611.4 | ₹1,450.1 |
| Market cap | ₹6,194 cr | ₹14,906 cr |
| P/E | — | 79.7 |
| P/B | — | — |
| ROE | 9.0% | 19.7% |
| ROCE | 14.6% | 19.6% |
| Debt / equity | 0.07 | 0.44 |
| Operating margin | — | 31.0% |
| Dividend yield | 0.00% | 0.14% |
| Sales growth, 3 years (yearly) | 31.6% | 21.0% |
| Profit growth, 3 years (yearly) | — | 26.9% |
| 1-year return | 24.8% | 45.6% |
| Revenue, last 12 months | — | ₹857 cr |
| Net profit, last 12 months | — | ₹187 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹32 cr | ₹53 cr |
| Quarter profit vs a year earlier | — | +38.5% |
| Promoter holding | 58.31% | 52.46% |
| Health check | Strong (7.8/10) | Strong (7.5/10) |
Common questions
Which earns a higher return on equity?
Vijaya Diagnostic Centre Ltd. (19.7% against 9.0%).
Which carries more debt?
Vijaya Diagnostic Centre Ltd. has the higher debt-to-equity ratio (0.44 against 0.07).